Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
about
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 bindingCD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatoryInhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressorsHIV-1 Vaccine Trials: Evolving Concepts and DesignsDiscordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection.Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Hepatitis C infection in HIV-1 natural viral suppressors.Hepatitis B vaccine responsiveness and clinical outcomes in HIV controllers.Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.Targeting γδ T cells for immunotherapy of HIV diseaseAltered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infection.Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study.Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature.A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies.Elevated hypermutation levels in HIV-1 natural viral suppressors.Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressorsCD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.An evaluation of HIV elite controller definitions within a large seroconverter cohort collaborationThe implications of viral reservoirs on the elite control of HIV-1 infection.Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.Finding a cure for human immunodeficiency virus-1 infection.Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral BurdensEvolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressorsPrimary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells.Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 Region.Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.Current Treatment Options for HIV Elite Controllers: a ReviewHIV control: Is getting there the same as staying there?
P2860
Q27675486-EB13CE69-C0B2-4D74-9582-560B3253B4DFQ28477861-DB4F8DC0-ED8B-4184-976E-DF3A830944CAQ28710569-68CB0044-1DC6-4C05-A3CF-DE04FE4E45A3Q30425520-13410D3E-70D6-4D28-838F-4BCF6DBDA272Q33410222-B858C012-8188-4084-B93C-F2A98CF5D3D7Q33755753-AD92557D-7A4D-46C1-B88A-04100B04FE0CQ33828349-1C4C7B56-8DD1-444C-8C6B-6CA0F835DDC5Q33952520-F95BA4E1-7447-4CA5-8F75-CA45CE0A0724Q34075566-DB956ACA-4125-4C80-900F-461F2517CA33Q34206267-FD88C7EF-6268-43D5-8C19-30F31CFAB434Q34585223-7FAFCAD0-DEE2-4D34-83B4-A085456EA9D7Q34611671-57231655-2D28-47F7-8D07-3B0EDBA992F4Q35001377-91F1BF2F-8640-4256-BEE0-D6D375356810Q35034034-B2AF8E1D-9B6C-410C-B8B0-0AF50AF3E638Q35661912-F6230D92-95C5-413B-A1C5-FE547FEB12D4Q36547178-1EEA94B3-9C1A-4C0A-A01B-9B56ADCDC60CQ36665336-F9A3B79D-2927-4011-8524-FBD674D1A5C8Q36833017-5A27732C-6B85-4C45-9305-F1A8ACC5C6ADQ36906910-1B2957AC-E01E-46A2-9DDB-50685ECB1DC3Q37145307-5F2FED6F-0FE7-4C7E-AD2D-529325D8C8E4Q37169522-0A5FB55B-D0B9-4F82-AF18-406D13F6E344Q37427587-413E57D3-63F7-482C-B55E-CC0648141823Q37525462-6F69A945-30B5-4D7D-A166-8346B48AD8A7Q38032153-3CD38522-2513-4D53-84B4-BD321B4F7256Q38098176-1FAA5A1D-7788-43CD-B351-29523B643512Q38256237-36D769DC-9630-49FA-9651-9FD9FB764261Q39425108-65AB775F-C348-433B-A85F-83072DFAF004Q40142539-348A7E5C-07DC-4581-AD8E-A743D16826CCQ40695938-7B4A49B4-8F0D-44BE-BB4C-665B9EE2F0E8Q41444622-F1E54422-01D2-4815-8867-1D7E9551A570Q41915015-7A9B6766-1A26-4745-A0C5-CE1773982D26Q41916926-2BD151A8-905A-4D15-A111-C3263C029BB1Q42737606-4A7D7B90-55A0-4CC6-B7CE-4E44488BF997Q47604797-CD5C94ED-6055-4FE8-841D-989B8C050896Q52680990-AB4F52D3-7E0B-4397-95DA-B8975E70555BQ57825309-940A7F71-1132-473E-A23C-EE26F7A6CF05Q58085173-FF8D008A-99C9-4924-A69F-19EFFB15CD33
P2860
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
@en
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
@nl
type
label
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
@en
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
@nl
prefLabel
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
@en
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
@nl
P2093
P2860
P1476
Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.
@en
P2093
Dean L Mann
Elham Dadzan
Manhattan Charurat
Mohammad M Sajadi
Neil T Constantine
Peter Kadlecik
Robert R Redfield
P2860
P304
P356
10.1097/QAI.0B013E3181945F1E
P407
P577
2009-04-01T00:00:00Z